Abstract
The study evaluates the efficacy of healthcare services outreach to disadvantaged and underprivileged persons in Europe. We conducted interviews and held focus groups to get a better understanding of these areas. We obtained qualitative data via these channels. Aside from assessing processes, descriptive statistics aided us in establishing how effectively these initiatives operate. According to the study, the target demographic may benefit greatly from pharmaceutical outreach initiatives due to the fact that they aid in healthcare access and, as a result, enhance health outcomes. To determine the overall impact of the treatments, qualitative data and descriptive statistics must be combined. Given the need for policymakers, healthcare providers, and other stakeholders to enhance health equality among Europe’s disadvantaged groups, this article presents some recommendations for reforming and scaling up pharmaceutical outreach projects in European nations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
